Literature DB >> 16944153

Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center.

M Funauchi1, H Shimadzu, C Tamaki, T Yamagata, Y Nozaki, M Sugiyama, S Ikoma, K Kinoshita.   

Abstract

Survival rate and causes of death according to the period of diagnosis and four accompanying organ disorders were analyzed in 306 Japanese patients with systemic lupus erythematosus. The survival rate was gradually improved, and the survival rate during 5- and 10-year periods of the patients diagnosed in 1990-2004 was 94 and 92%, 20-year period of those in 1980-1989 was 77%, 30-year period of those in 1975-1979 was 71%, respectively. Survival rate of those with serositis, pulmonary hypertension, and positive family history tended to be reduced, while that of the cases with neuropsychiatric disorder and renal disorder was significantly reduced. Overlapping of these organ disorders was an important factor for a poor prognosis. Bronchopneumonia and cerebrovascular accidents were frequent causes of death, and treatment for anti-phospholipid antibody syndrome and life-style diseases such as hypertension and arteriosclerosis was thought to be important for a good outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16944153     DOI: 10.1007/s00296-006-0201-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study.

Authors:  R Kasukawa; T Nishimaki; T Takagi; S Miyawaki; R Yokohari; T Tsunematsu
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

2.  Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years.

Authors:  M B Urowitz; D D Gladman; M Abu-Shakra; V T Farewell
Journal:  J Rheumatol       Date:  1997-06       Impact factor: 4.666

Review 3.  Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.

Authors:  A Tyndall; R Saccardi
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus.

Authors:  Paivi M Miettunen; Oliva Ortiz-Alvarez; Ross E Petty; Rolando Cimaz; Peter N Malleson; David A Cabral; Stephanie Ensworth; Lori B Tucker
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

5.  Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States.

Authors:  R A Kaslow; A T Masi
Journal:  Arthritis Rheum       Date:  1978-05

6.  Pulmonary hypertension in systemic lupus.

Authors:  S R Johnson; D D Gladman; M B Urowitz; D Ibañez; J T Granton
Journal:  Lupus       Date:  2004       Impact factor: 2.911

7.  Accrual of organ damage over time in patients with systemic lupus erythematosus.

Authors:  Dafna D Gladman; Murray B Urowitz; Proton Rahman; Dominique Ibañez; Lai-Shan Tam
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

8.  Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort.

Authors:  M M Ward; E Pyun; S Studenski
Journal:  Arthritis Rheum       Date:  1995-10

9.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

10.  Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

Authors:  M Abu-Shakra; M B Urowitz; D D Gladman; J Gough
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more
  7 in total

Review 1.  Mortality in Systemic Lupus Erythematosus: an Updated Review.

Authors:  César E Fors Nieves; Peter M Izmirly
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

2.  Causes and predictors of death in Brazilian lupus patients.

Authors:  Rosa Weiss Telles; Cristina Costa Duarte Lanna; Fabiana Lemos Souza; Luciana Andrade Rodrigues; Rodrigo Citton Padilha Reis; Antonio Luiz Ribeiro
Journal:  Rheumatol Int       Date:  2012-03-30       Impact factor: 2.631

3.  The lupus band test in systemic lupus erythematosus patients.

Authors:  Adam Reich; Katarzyna Marcinow; Rafal Bialynicki-Birula
Journal:  Ther Clin Risk Manag       Date:  2011-01-24       Impact factor: 2.423

4.  Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.

Authors:  Hong Ki Min; Jae Ho Lee; Seung Min Jung; Jennifer Lee; Kwi Young Kang; Seung-Ki Kwok; Ji Hyeon Ju; Kyung-Su Park; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

5.  Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.

Authors:  Johanna T Gustafsson; Julia F Simard; Iva Gunnarsson; Kerstin Elvin; Ingrid E Lundberg; Lars-Olof Hansson; Anders Larsson; Elisabet Svenungsson
Journal:  Arthritis Res Ther       Date:  2012       Impact factor: 5.156

6.  Pulmonary arterial hemodynamic assessment by a novel index in systemic lupus erythematosus patients: pulmonary pulse transit time.

Authors:  Tolga Han Efe; Mehmet Doğan; Cem Özişler; Tolga Çimen; Mehmet Ali Felekoğlu; Ahmet Göktuğ Ertem; Engin Algül; Sadık Açıkel
Journal:  Anatol J Cardiol       Date:  2017-06-22       Impact factor: 1.596

7.  Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.

Authors:  Irene E M Bultink; Frank de Vries; Ronald F van Vollenhoven; Arief Lalmohamed
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.